Public perceptions of tobacco biopharming

AgBioForum

Volumn 9, Issue 2, 2006, Pages 104-110

  Nevitt, Jonathan ^a   Mills, Bradford F ^a   Reaves, Dixie W ^a   Norton, George W ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Agricultural biotechnology; Biopharming; Consumer surveys; Genetically modified (GM) crops; Plant made pharmaceuticals; Risk perception; Technology acceptance; Transgenic tobacco; Willingness to purchase

Indexed keywords

NICOTIANA TABACUM;

EID: 33749323554     PISSN: 1522936X     EISSN: 1522936X     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. American Association of Blood Banks. (2005). Receiving a blood transfusion: What every patient should know. Bethesda, MD: AABB. Available on the World Wide Web: http://www.aabb.org.
2. Blaine, K., Kamaldeen, S., & Powell, D. (2002). Public perceptions of biotechnology. Journal of Food Science, 67(9), 3200-3208.
3. Einsiedel, E.F., & Medlock, J. (2005). A public consultation on plant molecular farming. AgBioForum, 8(1), 26-32. Available on the World Wide Web: http://www.agbioforum.org.
4. Elbehri, A. (2005). Biopharming and the food system: Examining the potential benefits and risks. AgBioForum, 8(1), 18-25. Available on the World Wide Web: http://www.agbioforum.org.
5. Fernandez, M., Crawford, L., & Hefferan, C. (2002, July). Pharming the field: A look at the benefits and risks of bioengineering plants to produce pharmaceuticals. Proceedings from a joint workshop sponsored by the Pew Initiative on Food and Biotechnology, FDA, and USDA. Washington, DC: Pew Initiative on Food and Biotechnology. Available on the World Wide Web: http://pewagbiotech.org/events/0717/ConferenceReport.pdf.
6. Frewer, L. (2003). Societal issues and public attitudes towards genetically modified foods. Trends in Food Science & Technology, 14, 319-332.
7. Harrison, R.W., Boccaletti, S., & House, L. (2004). Risk perceptions of urban Italian and United States consumers for genetically modified foods. AgBioForum, 7(4), 195-201. Available on the World Wide Web: http://www. agbioforum.org.
8. Hoban, T.J. (1999). Consumer acceptance of biotechnology in the United States and Japan. Food Technology, 53(5), 50-53
9. International Food Information Council. (2005). IFIC survey: Food biotechnology not a top-of-mind concern for American consumers. Washington, DC: IFIC.Available on the World Wide Web: http://www.ific.org.
10. Moon, W., & Balasubramanian, S.K. (2004). Public attitudes toward agrobiotechnology: The mediating role of risk perceptions on the impact of trust, awareness, and outrage. Review of Agricultural Economics, 26(2), 186-208.
11. Pew Initiative on Food and Biotechnology. (2004). Overview of findings: 2004 focus groups & poll. Washington, DC: Author. Available on the World Wide Web: http://www.pewagbiotech.org.
12. Priest, S.H. (2000). US public opinion divided over biotechnology? Nature Biotechnology, 18, 939-942. Available on the World Wide Web: http://biotech.nature.com.
13. United States Department of Agriculture. (2005). Permitting genetically engineered plants that produce pharmaceutical compounds. Washington, DC: USDA. Available on the World Wide Web: http://www.aphis.usda.gov/lpa/pubs/ fsheet_faq_notice/fs_brspharmaceutical.pdf.
14. United States Food and Drug Administration. (2002). Guidance for industry: Drugs, biologics, and medical devices derived from bioengineered plants for use in humans and animals. Washington, DC: USFDA. Available on the World Wide Web: http://www.fda.gov/cber/gdlns/bioplant.pdf.